Name
Integrating Available Medications in Primary Care for management of Fatty Liver disease
Date & Time
Thursday, December 4, 2025, 7:55 PM - 8:25 PM
Speakers
Description
- Review the role of GLP-1s, statins, insulin sensitizers, and emerging therapies in MASLD/MASH management.
- Evaluate medication choices considering comorbidities such as T2D, obesity, CKLM and bariatric surgery
- Summarize current and upcoming guidelines for pharmacologic management.